Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families

Molecular Psychiatry

Volumn 23, Issue 4, 2018, Pages 973-984

  Harripaul, R ^a,b   Vasli, N ^a   Mikhailov, A ^a   Rafiq, M A ^a,c   Mittal, K ^a   Windpassinger, C ^d   Sheikh, T I ^a,b   Noor, A ^b,e   Mahmood, H ^a   Downey, S ^a,f   Johnson, M ^a,f   Vleuten, K ^a,f   Bell, L ^a,f   Ilyas, M ^g   Khan, F S ^h   Khan, V ^h   Moradi, M ⁱ   Ayaz, M ^j   Naeem, F ^j,k   Heidari, A ^a,l   Ahmed, I ^m   Ghadami, S ⁿ   Agha, Z ^c   Zeinali, S ⁿ   Qamar, R ^c,o   Mozhdehipanah, H ⁱ   John, P ^m   Mir, A ^g   Ansar, M ^h   French, L ^a   Ayub, M ^j,k   Vincent, J B ^a,b,p   more..

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c COMSATS Institute of Information Technology ^*  (Pakistan)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e MOUNT SINAI HOSPITAL   (Canada)

^f Fleming College   (Canada)

^g INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

^h QUAID I AZAM UNIVERSITY   (Pakistan)

ⁱ QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j Lahore Institute of Research and Development   (Pakistan)

^k QUEEN S UNIVERSITY   (Canada)

^l HOSPITAL FOR SICK CHILDREN   (Canada)

^m NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

ⁿ PASTEUR INSTITUTE OF IRAN   (Iran)

^o ISRA UNIVERSITY   (Pakistan)

^p UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHROMOSOMAL MAPPING; CONSANGUINITY; COPY NUMBER VARIATION; FAMILY; FEMALE; GENETIC HETEROGENEITY; GENETICS; HOMOZYGOTE; HUMAN; INTELLECTUAL IMPAIRMENT; IRAN; LOSS OF FUNCTION MUTATION; MALE; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; MUTATION; PAKISTAN; PEDIGREE; PROCEDURES; RECESSIVE GENE; WHOLE EXOME SEQUENCING;

ADULT; CHROMOSOME MAPPING; CONSANGUINITY; DNA COPY NUMBER VARIATIONS; FAMILY; FEMALE; GENES, RECESSIVE; GENETIC HETEROGENEITY; HOMOZYGOTE; HUMANS; INTELLECTUAL DISABILITY; IRAN; LOSS OF FUNCTION MUTATION; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUTATION; PAKISTAN; PEDIGREE; WHOLE EXOME SEQUENCING;

EID: 85017518703     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.60     Document Type: Article

References (90)

1. Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disab 2011; 32: 419–436.
2. Vissers LE, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet 2015; 17: 9–18.
3. Ropers H-H, Hamel BC. X-linked mental retardation. Nat Rev Genet 2005; 6: 46–57.
4. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012; 367: 1921–1929.
5. Hamdan FF, Srour M, Capo-Chichi J-M, Daoud H, Nassif C, Patry L et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet 2014; 10: e1004772.
6. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014; 511: 344–7.
7. Musante L, Ropers HH. Genetics of recessive cognitive disorders. Trends Genet 2014; 30: 32–39.
8. Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, Becker C et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet Part A 2006; 140: 2063–2074.
9. Heslop P, Blair PS, Fleming P, Hoghton M, Marriott A, Russ L. The Confidential Inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study. Lancet 2014; 383: 889–895.
10. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. New Engl J Med 2013; 369: 1502–1511.
11. Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011; 478: 57–63.
12. Mir A, Kaufman L, Noor A, Motazacker MM, Jamil T, Azam M et al. Identification of mutations in TRAPPC9, which encodes the NIK-and IKK-β-binding protein, in nonsyndromic autosomal-recessive mental retardation. Am J Hum Genet 2009; 85: 909–915.
13. Rafiq MA, Kuss AW, Puettmann L, Noor A, Ramiah A, Ali G et al. Mutations in the alpha 1, 2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. Am J Hum Genet 2011; 89: 176–182.
14. Bernkopf M, Webersinke G, Tongsook C, Koyani CN, Rafiq MA, Ayaz M et al. Disruption of the methyltransferase-like 23 gene METTL23 causes mild autosomal recessive intellectual disability. Hum Mol Genet 2014; 23: 4015–4023.
15. Law R, Dixon-Salazar T, Jerber J, Cai N, Abbasi AA, Zaki MS et al. Biallelic truncating mutations in FMN2, encoding the actin-regulatory protein formin 2, cause nonsyndromic autosomal-recessive intellectual disability. Am J Hum Genet 2014; 95: 721–728.
16. Ahmed I, Buchert R, Zhou M, Jiao X, Mittal K, Sheikh TI et al. Mutations in DCPS and EDC3 in autosomal recessive intellectual disability indicate a crucial role for mRNA decapping in neurodevelopment. Hum Mol Genet 2015; 24: 3172–3180.
17. Heidari A, Tongsook C, Najafipour R, Musante L, Vasli N, Garshasbi M et al. Mutations in the histamine N-methyltransferase gene, HNMT, are associated with nonsyndromic autosomal recessive intellectual disability. Hum Mol Genet 2015; 24: 5697–5710.
18. Modell B, Darr A. Genetic counselling and customary consanguineous marriage. Nat Rev Genet 2002; 3: 225–229.
19. Hamamy H. Consanguineous marriages. J Commun Genet 2012; 3: 185–192.
20. Saadat M. Consanguinity associated with child and adult mortality in 24 Asian and African countries, an ecological study. Iranian J Pub Health 2007; 36: 35–39.
21. Hussain R, Bittles A. The prevalence and demographic characteristics of consanguineous marriages in Pakistan. J Biosoc Sci 1998; 30: 261–275.
22. Najmabadi H, Motazacker MM, Garshasbi M, Kahrizi K, Tzschach A, Chen W et al. Homozygosity mapping in consanguineous families reveals extreme heterogeneity of non-syndromic autosomal recessive mental retardation and identifies 8 novel gene loci. Hum Genet 2007; 121: 43–48.
23. Haddad LA, Mingroni-Netto RC, Vianna-Morgante AM, Pena SD. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males. Hum Genet 1996; 97: 808–812.
24. Gazal S, Sahbatou M, Babron M-C, Génin E, Leutenegger A-L. FSuite: exploiting inbreeding in dense SNP chip and exome data. Bioinformatics 2014; 30: 1940–1941.
25. Seelow D, Schuelke M, Hildebrandt F, Nürnberg P. HomozygosityMapper—an interactive approach to homozygosity mapping. Nucleic Acids Res 2009; 37 (suppl 2): W593–W599.
26. Gazal S, Sahbatou M, Babron MC, Genin E, Leutenegger AL. FSuite: exploiting inbreeding in dense SNP chip and exome data. Bioinformatics 2014; 30: 1940–1941.
27. Mir A, Sritharan K, Mittal K, Vasli N, Araujo C, Jamil T et al. Truncation of the E3 ubiquitin ligase component FBXO31 causes non-syndromic autosomal recessive intellectual disability in a Pakistani family. Hum Genet 2014; 133: 975–984.
28. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS et al. Human gene mutation database (HGMD): 2003 update. Hum Mutation 2003; 21: 577–581.
29. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005; 33 (suppl 1): D514–D517.
30. Bradford Y, Conlin T, Dunn N, Fashena D, Frazer K, Howe DG et al. ZFIN: enhancements and updates to the Zebrafish Model Organism Database. Nucleic Acids Res 2011; 39 (suppl 1): D822–D829.
31. Darnell JC, Van Driesche SJ, Zhang C, Hung KYS, Mele A, Fraser CE et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011; 146: 247–261.
32. Noor A, Windpassinger C, Patel M, Stachowiak B, Mikhailov A, Azam M et al. CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa. Am J Hum Genet 2008; 82: 1011–1018.
33. Sang L, Miller JJ, Corbit KC, Giles RH, Brauer MJ, Otto EA et al. Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. Cell 2011; 145: 513–528.
34. Khan MA, Rafiq MA, Noor A, Hussain S, Flores JV, Rupp V et al. Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability. Am J Hum Genet 2012; 90: 856–863.
35. Johansen A, Rosti RO, Musaev D, Sticca E, Harripaul R, Zaki M et al. Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, lead to intellectual disability accompanied by epilepsy and autistic features. Am J Hum Genet 2016; 99: 912–916.
36. Marangi G, Leuzzi V, Manti F, Lattante S, Orteschi D, Pecile V et al. TRAPPC9-related autosomal recessive intellectual disability: report of a new mutation and clinical phenotype. Eur J Hum Genet 2013; 21: 229–232.
37. Van Scherpenzeel M, Timal S, Rymen D, Hoischen A, Wuhrer M, Hipgrave-Ederveen A et al. Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency. Brain 2014; 137: 1030–1038.
38. Narasimhan VM, Hunt KA, Mason D, Baker CL, Karczewski KJ, Barnes MR et al. Health and population effects of rare gene knockouts in adult humans with related parents. Science 2016; 352: 474–477.
39. Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP et al. Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS ONE 2012; 7: e28936.
40. Mochida GH, Mahajnah M, Hill AD, Basel-Vanagaite L, Gleason D, Hill RS et al. A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly. Am J Hum Genet 2009; 85: 897–902.
41. Philippe O, Rio M, Carioux A, Plaza J-M, Guigue P, Molinari F et al. Combination of linkage mapping and microarray-expression analysis identifies NF-κB signaling defect as a cause of autosomal-recessive mental retardation. Am J Hum Genet 2009; 85: 903–908.
42. Jamra RA, Wohlfart S, Zweier M, Uebe S, Priebe L, Ekici A et al. Homozygosity mapping in 64 Syrian consanguineous families with non-specific intellectual disability reveals 11 novel loci and high heterogeneity. Eur J Hum Genet 2011; 19: 1161–1166.
43. Kakar N, Goebel I, Daud S, Nürnberg G, Agha N, Ahmad A et al. A homozygous splice site mutation in TRAPPC9 causes intellectual disability and microcephaly. Eur J Med Genet 2012; 55: 727–731.
44. van der Vaart B, Franker MA, Kuijpers M, Hua S, Bouchet BP, Jiang K et al. Microtubule plus-end tracking proteins SLAIN1/2 and ch-TOG promote axonal development. J Neurosci 2012; 32: 14722–14728a.
45. Figueiredo T, Melo U, Pessoa A, Nobrega P, Kitajima J, Rusch H et al. A homozygous loss-of-function mutation in inositol monophosphatase 1 (IMPA1) causes severe intellectual disability. Mol Psychiatry 2015; 21: 1125–9.
46. Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, Van Kogelenberg M et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet 2015; 385: 1305–1314.
47. Franić S, Groen-Blokhuis MM, Dolan CV, Kattenberg MV, Pool R, Xiao X et al. Intelligence: shared genetic basis between Mendelian disorders and a polygenic trait. Eur J Hum Genet 2015; 23: 1378–83.
48. Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012; 64: 238–258.
49. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003; 302: 885–889.
50. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003; 302: 890–893.
51. Dong E, Ruzicka W, Grayson D, Guidotti A. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients. Schizophr Res 2015; 167: 35–41.
52. Zhubi A, Chen Y, Dong E, Cook E, Guidotti A, Grayson D. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl Psychiatry 2014; 4: e349.
53. Dong E, Gavin DP, Chen Y, Davis J. Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry 2012; 2: e159.
54. Zhang R-R, Cui Q-Y, Murai K, Lim YC, Smith ZD, Jin S et al. Tet1 regulates adult hippocampal neurogenesis and cognition. Cell Stem Cell 2013; 13: 237–245.
55. Li C, Lan Y, Schwartz-Orbach L, Korol E, Tahiliani M, Evans T et al. Overlapping requirements for Tet2 and Tet3 in normal development and hematopoietic stem cell emergence. Cell Rep 2015; 12: 1133–1143.
56. Metsu S, Rooms L, Rainger J, Taylor MS, Bengani H, Wilson DI et al. FRA2A is a CGG repeat expansion associated with silencing of AFF3. PLoS Genet 2014; 10: e1004242.
57. Wade EM, Daniel PB, Jenkins ZA, McInerney-Leo A, Leo P, Morgan T et al. Mutations in MAP3K7 that alter the activity of the TAK1 signaling complex cause frontometaphyseal dysplasia. Am J Hum Genet 2016; 99: 392–406.
58. Le Goff C, Rogers C, Le Goff W, Pinto G, Bonnet D, Chrabieh M et al. Heterozygous Mutations in MAP3K7, Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome. Am J Hum Genet 2016; 99: 407–413.
59. Hu H, Haas S, Chelly J, Van Esch H, Raynaud M, de Brouwer A et al. X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes. Mol Psychiatry 2016; 21: 133–148.
60. Rual J-F, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N et al. Towards a proteome-scale map of the human protein–protein interaction network. Nature 2005; 437: 1173–1178.
61. Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N et al. A proteome-scale map of the human interactome network. Cell 2014; 159: 1212–1226.
62. Yu H, Tardivo L, Tam S, Weiner E, Gebreab F, Fan C et al. Next-generation sequencing to generate interactome datasets. Nat Methods 2011; 8: 478–480.
63. McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry 2014; 19: 652.
64. Mittal K, Rafiq MA, Rafiullah R, Harripaul R, Ali H, Ayaz M et al. Mutations in the genes for thyroglobulin and thyroid peroxidase cause thyroid dyshormonogenesis and autosomal-recessive intellectual disability. J Hum Genet 2016; 61: 867–872.
65. Pagnamenta AT, Bacchelli E, de Jonge MV, Mirza G, Scerri TS, Minopoli F et al. Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry 2010; 68: 320–328.
66. Kevelam SH, van Harssel JJ, van der Zwaag B, Smeets HJ, Paulussen AD, Lichtenbelt KD. A patient with a mild holoprosencephaly spectrum phenotype and heterotaxy and a 1.3 Mb deletion encompassing GLI2. Am J Med Genet Part A 2012; 158: 166–173.
67. Barber JC, Maloney VK, Bewes B, Wakeling E. Deletions of 2q14 that include the homeobox engrailed 1 (EN1) transcription factor are compatible with a normal phenotype. Eur J Hum Genet 2006; 14: 739–743.
68. Khan MA, Rafiq MA, Noor A, Ali N, Ali G, Vincent JB et al. A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with autosomal recessive nonsyndromic intellectual disability. BMC Med Genet 2011; 12: 56.
69. Rafiq MA, Leblond CS, Saqib MA, Vincent AK, Ambalavanan A, Khan FS et al. Novel VPS13B mutations in three large Pakistani cohen syndrome families suggests a Baloch variant with autistic-like features. BMC Med Genet 2015; 16: 41.
70. Hall J, Owen MJ. Psychiatric classification–a developmental perspective. Br J Psychiatry 2015; 207: 281–282.
71. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014; 506: 185–190.
72. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179–184.
73. Nan X, Hou J, Maclean A, Nasir J, Lafuente MJ, Shu X et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci 2007; 104: 2709–2714.
74. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519–523.
75. Clarke T, Lupton M, Fernandez-Pujals A, Starr J, Davies G, Cox S et al. Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population. Mol Psychiatry 2015; 21: 419–25.
76. Davies G, Marioni RE, Liewald DC, Hill WD, Hagenaars SP, Harris SE et al. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N= 112 151). Mol Psychiatry 2016; 21: 758–67.
77. Huang J, Zhu T, Qu Y, Mu D. Prenatal, perinatal and neonatal risk factors for intellectual disability: a systemic review and meta-analysis. PLoS ONE 2016; 11: e0153655.
78. Singh T, Kurki MI, Curtis D, Purcell SM, Crooks L, McRae J et al. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci 2016; 19: 571–7.
79. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014; 515: 209–215.
80. Li J, Cai T, Jiang Y, Chen H, He X, Chen C et al. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database. Mol Psychiatry 2015; 21: 298.
81. Sun L, Dimitromanolakis A. PREST-plus identifies pedigree errors and cryptic relatedness in the GAW18 sample using genome-wide SNP data. BMC Proc 2014; 8: S23.
82. Riazuddin S, Hussain M, Razzaq A, Iqbal Z, Shahzad M, Polla D et al. Exome sequencing of Pakistani consanguineous families identifies 30 novel candidate genes for recessive intellectual disability. Mol Psychiatry 2016 [e-pub ahead of print].
83. Philips AK, Pinelli M, de Bie CI, Mustonen A, Määttä T, Arts HH et al. Identification of C12orf4 as a gene for autosomal recessive intellectual disability. Clin Genet 2016; 91: 100–105.
84. Alazami AM, Patel N, Shamseldin HE, Anazi S, Al-Dosari MS, Alzahrani F et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep 2015; 10: 148–161.
85. Vasli N, Ahmed I, Mittal K, Ohadi M, Mikhailov A, Rafiq MA et al. Identification of a homozygous missense mutation in LRP2 and a hemizygous missense mutation in TSPYL2 in a family with mild intellectual disability. Psychiatric genetics 2016; 26: 66–73.
86. Garshasbi M, Hadavi V, Habibi H, Kahrizi K, Kariminejad R, Behjati F et al. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. The American Journal of Human Genetics 2008; 82: 1158–1164.
87. Celis K, Shuldiner S, Haverfield EV, Cappell J, Yang R, Gong D-W et al. Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2) causes developmental encephalopathy. Journal of inherited metabolic disease 2015; 38: 941–948.
88. Caldovic L, Morizono H, Panglao MG, Cheng SF, Packman S, Tuchman M. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia. Human genetics 2003; 112: 364–368.
89. Kutsche K, Yntema H, Brandt A, Jantke I, Nothwang HG, Orth U et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nature genetics 2000; 26: 247–250.
90. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature genetics 1999; 23: 185–188.